NON-SMALL CELL LUNG CANCER STAGE IIIB

Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IIIB explained in plain language.

Never miss a new study

Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIB trials appear

Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New hope for Tough-to-Treat lung cancer patients

Disease control Ongoing

This early-stage study is testing whether combining two existing cancer drugs—ceritinib and docetaxel—can help control advanced lung cancer that has stopped responding to standard chemotherapy. The trial aims to find the safest dose of this combination and see if it can shrink tu…

Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIB

Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

NON-SMALL CELL LUNG CANCER STAGE IIIB

Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIB trials appear

New hope for Tough-to-Treat lung cancer patients